Gianna is an associate editor of The American Journal of Managed Care® (AJMC®). She has been working on AJMC® since 2019 and has a BA in philosophy and journalism & professional writing from The College of New Jersey.
How Can the Health Care Industry Help Tackle Climate Change?
In a talk presented by The Hastings Center, Gary Cohen, president of Health Care Without Harm, explains how the health care industry can fight climate change, mitigate social determinants of health, and reduce costs through a series of targeted efforts.
Dr Marc-Andre Cornier Explains How the Pandemic Could Increase US Weight Gain
Marc-Andre Cornier, MD, professor and director of the Division of Endocrinology, Diabetes and Metabolic Diseases at the Medical University of South Carolina, discusses factors that could worsen US obesity rates.
Dr Marc-Andre Cornier on the Importance of Behavioral Interventions for Weight Loss
Marc-Andre Cornier, MD, professor and director of the Division of Endocrinology, Diabetes and Metabolic Diseases at the Medical University of South Carolina, outlines the necessary components for a successful weight loss program.
Higher DKA Rates Seen in Black Patients With T1D Throughout COVID-19
Compared with other racial/ethnic groups, Black patients with type 1 diabetes (T1D) presented to medical centers with diabetic ketoacidosis (DKA) more often throughout the COVID-19 pandemic, regardless of COVID-19 infection.
Dr Marc-Andre Cornier Discusses COVID-19's Impact on a Weight Loss Intervention Program
Marc-Andre Cornier, MD, professor and director of the Division of Endocrinology, Diabetes and Metabolic Diseases at the Medical University of South Carolina, explains recent research on a behavioral weight loss intervention.
EMPULSE: Empagliflozin Yields QOL Benefits in Patients Hospitalized for Acute HF
Patients hospitalized for acute heart failure and prescribed empagliflozin saw improvements in quality of life at 15 and 90 days post-discharge. The study may make the case for prescribing SGLT2 inhibitors before patients leave the hospital.
SCORED: Sotagliflozin Leads to Reductions in CV Death, MI, Stroke Regardless of CVD Presence
Additional analyses from the SCORED trial further highlight sotagliflozin's benefits among patients with type 2 diabetes and chronic kidney disease, regardless of cardiovascular disease presence.
Abstracts Outline Costs of Heart Health in US, Benefits of Protective Measures
New research presented at the American College of Cardiology's 71st Annual Scientific Session & Expo highlights the high costs of heart failure in the United States and the benefits of healthy eating and exercise as preventive measures.